Conditioning-based therapeutics for aneurysmal subarachnoid hemorrhage - A critical review
Aneurysmal subarachnoid hemorrhage (SAH) carries significant mortality and morbidity, with nearly half of SAH survivors having major cognitive dysfunction that impairs their functional status, emotional health, and quality of life. Apart from the initial hemorrhage severity, secondary brain injury due to early brain injury and delayed cerebral ischemia plays a leading role in patient outcome after SAH. While many strategies to combat secondary brain injury have been developed in preclinical studies and tested in late phase clinical trials, only one (nimodipine) has proven efficacious for improving long-term functional outcome. The causes of these failures are likely multitude, but include use of therapies targeting only one element of what has proven to be multifactorial brain injury process. Conditioning is a therapeutic strategy that leverages endogenous protective mechanisms to exert powerful and remarkably pleiotropic protective effects against injury to all major cell types of the CNS. The aim of this article is to review the current body of evidence for the use of conditioning agents in SAH, summarize the underlying neuroprotective mechanisms, and identify gaps in the current literature to guide future investigation with the long-term goal of identifying a conditioning-based therapeutic that significantly improves functional and cognitive outcomes for SAH patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism - 44(2024), 3 vom: 28. März, Seite 317-332 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pugazenthi, Sangami [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 16.02.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/0271678X231218908 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365085529 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365085529 | ||
| 003 | DE-627 | ||
| 005 | 20240320233714.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/0271678X231218908 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM365085529 | ||
| 035 | |a (NLM)38017387 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pugazenthi, Sangami |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Conditioning-based therapeutics for aneurysmal subarachnoid hemorrhage - A critical review |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.02.2024 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Aneurysmal subarachnoid hemorrhage (SAH) carries significant mortality and morbidity, with nearly half of SAH survivors having major cognitive dysfunction that impairs their functional status, emotional health, and quality of life. Apart from the initial hemorrhage severity, secondary brain injury due to early brain injury and delayed cerebral ischemia plays a leading role in patient outcome after SAH. While many strategies to combat secondary brain injury have been developed in preclinical studies and tested in late phase clinical trials, only one (nimodipine) has proven efficacious for improving long-term functional outcome. The causes of these failures are likely multitude, but include use of therapies targeting only one element of what has proven to be multifactorial brain injury process. Conditioning is a therapeutic strategy that leverages endogenous protective mechanisms to exert powerful and remarkably pleiotropic protective effects against injury to all major cell types of the CNS. The aim of this article is to review the current body of evidence for the use of conditioning agents in SAH, summarize the underlying neuroprotective mechanisms, and identify gaps in the current literature to guide future investigation with the long-term goal of identifying a conditioning-based therapeutic that significantly improves functional and cognitive outcomes for SAH patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Conditioning strategies | |
| 650 | 4 | |a delayed cerebral ischemia | |
| 650 | 4 | |a early brain injury | |
| 650 | 4 | |a neurologic outcomes | |
| 650 | 4 | |a neurovascular protection | |
| 650 | 4 | |a subarachnoid hemorrhage | |
| 650 | 7 | |a Nimodipine |2 NLM | |
| 650 | 7 | |a 57WA9QZ5WH |2 NLM | |
| 700 | 1 | |a Norris, Aaron J |e verfasserin |4 aut | |
| 700 | 1 | |a Lauzier, David C |e verfasserin |4 aut | |
| 700 | 1 | |a Lele, Abhijit V |e verfasserin |4 aut | |
| 700 | 1 | |a Huguenard, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Dhar, Rajat |e verfasserin |4 aut | |
| 700 | 1 | |a Zipfel, Gregory J |e verfasserin |4 aut | |
| 700 | 1 | |a Athiraman, Umeshkumar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism |d 1986 |g 44(2024), 3 vom: 28. März, Seite 317-332 |w (DE-627)NLM012901814 |x 1559-7016 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2024 |g number:3 |g day:28 |g month:03 |g pages:317-332 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/0271678X231218908 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2024 |e 3 |b 28 |c 03 |h 317-332 | ||